XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
UNAUDITED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 142,170 $ 103,093
Accounts receivable-trade, net 597,363 504,122
Accounts receivable-other, net 50,055 55,508
Inventories 218,046 243,286
Financing receivables-net, current 110,344 89,829
Deferred costs 54,279 44,191
Other current assets 47,057 55,101
Total current assets 1,219,314 1,095,130
Financing receivables and operating leases-net 87,012 84,417
Deferred tax asset 3,682 3,682
Property, equipment, and other assets-net 84,335 70,447
Goodwill 158,284 136,105
Other intangible assets-net 42,970 25,045
TOTAL ASSETS 1,595,597 1,414,826
Current liabilities:    
Accounts payable 294,705 220,159
Accounts payable-floor plan 92,518 134,615
Salaries and commissions payable 45,372 37,336
Deferred revenue 130,352 114,028
Other current liabilities 32,351 24,372
Total current liabilities 631,463 561,326
Non-recourse notes payable - long-term 12,233 9,522
Deferred tax liability 561 715
Other liabilities 73,587 60,998
TOTAL LIABILITIES 717,844 632,561
COMMITMENTS AND CONTINGENCIES (Note 9)
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 per share par value; 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 per share par value; 50,000 shares authorized; 26,954 outstanding at December 31, 2023 and 26,905 outstanding at March 31, 2023 274 272
Additional paid-in capital 177,465 167,303
Treasury stock, at cost, 446 shares at December 31, 2023 and 261 shares at March 31, 2023 (23,774) (14,080)
Retained earnings 720,995 627,202
Accumulated other comprehensive income-foreign currency translation adjustment 2,793 1,568
Total Stockholders' Equity 877,753 782,265
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 1,595,597 1,414,826
Recourse [Member]    
Current liabilities:    
Notes payable-current 0 5,997
Non-recourse [Member]    
Current liabilities:    
Notes payable-current $ 36,165 $ 24,819